1. Home
  2. PHAR vs QSI Comparison

PHAR vs QSI Comparison

Compare PHAR & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$10.97

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

HOLD

Current Price

$0.75

Market Cap

165.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAR
QSI
Founded
1988
2013
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
165.6M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
PHAR
QSI
Price
$10.97
$0.75
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$38.33
$1.00
AVG Volume (30 Days)
20.7K
2.6M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.17
EPS
N/A
N/A
Revenue
N/A
$2,436,000.00
Revenue This Year
$10.04
N/A
Revenue Next Year
$2.51
$618.07
P/E Ratio
$3,041.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.62
$0.69
52 Week High
$21.34
$3.10

Technical Indicators

Market Signals
Indicator
PHAR
QSI
Relative Strength Index (RSI) 42.27 44.01
Support Level $11.03 $0.70
Resistance Level $13.51 $1.04
Average True Range (ATR) 0.35 0.05
MACD -0.01 -0.00
Stochastic Oscillator 4.72 2.16

Price Performance

Historical Comparison
PHAR
QSI

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Share on Social Networks: